SCHEMBL4764102

SCHEMBL4764102

CCOc1ccccc1-c1[c]occ1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
HPGD P15428 2/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
PPARG P37231 1/20 0.43
STAT3 P40763 1/20 0.43
NCOA2 Q15596 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
PTPRC P08575 1/20 0.42
NPSR1 Q6W5P4 2/20 0.40
TTR P02766 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
PDK2 Q15119 1/20 0.39
EGFR P00533 1/20 0.39
ENPP3 O14638 1/20 0.39
ENPP1 P22413 1/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4723552 0.89 CYP1A2 (0.41) ALDH1A1HPGDMAPTKDM4ENPSR1
SCHEMBL4765642 0.87 CYP1A2 (0.50) ALDH1A1MAPTKDM4ETDP1L3MBTL1
SCHEMBL3937269 0.85 LMNA (0.35) ALDH1A1HPGDMAPTKDM4EPPARG
SCHEMBL4765612 0.82 APP (0.44) ALDH1A1HPGDKDM4EPPARGNCOA2
SCHEMBL198911 0.77 ALDH1A1 (0.60) ALDH1A1HPGDMAPTKDM4EPPARG
SCHEMBL5541261 0.76 ALDH1A1 (0.42) ALDH1A1MAPTKDM4ENPSR1L3MBTL1
SCHEMBL447310 0.74 ALDH1A1 (0.44) ALDH1A1HPGDMAPTKDM4EPPARG
SCHEMBL10471232 0.72 NPC1 (0.41) ALDH1A1HPGDKDM4EPPARGNCOA2
SCHEMBL2123412 0.71 TTR (0.46) ALDH1A1HPGDMAPTKDM4EPPARG
SCHEMBL19003058 0.71 ALDH1A1 (0.42) ALDH1A1HPGDMAPTKDM4EPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed
EP-1874780-A1 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2008-01-09 EP disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors TBXA2R, P2RY4, PF4 ALDH1A1 622/4885HPGD 800/4885MAPT 4361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.